National Antimicrobial Resistance Monitoring System

National Antimicrobial Resistance Monitoring System
Name	National Antimicrobial Resistance Monitoring System
Formation	1996
Type	Surveillance program
Headquarters	United States
Parent organization	Centers for Disease Control and Prevention
Partners	Food and Drug Administration; United States Department of Agriculture; state public health laboratories

National Antimicrobial Resistance Monitoring System

The National Antimicrobial Resistance Monitoring System is a United States surveillance program that tracks antimicrobial resistance among enteric bacteria in humans, retail meats, and food animals. It integrates activities from the Centers for Disease Control and Prevention, the Food and Drug Administration, and the United States Department of Agriculture to inform public health, regulatory action, and research. The program's data have been used by policymakers, academic researchers, and international organizations to evaluate trends in resistance and guide interventions.

Overview

The program conducts coordinated surveillance across clinical, food, and veterinary sectors, sampling pathogens such as Salmonella, Campylobacter, and Escherichia coli to detect antimicrobial resistance patterns. It links laboratory data with epidemiologic investigations performed by state and territorial public health agencies including New York State Department of Health, California Department of Public Health, and Texas Department of State Health Services. Outputs are incorporated into reports and databases used by entities such as the World Health Organization, Pan American Health Organization, and the European Centre for Disease Prevention and Control. Stakeholders include researchers at institutions like Johns Hopkins University, Harvard T.H. Chan School of Public Health, and Iowa State University and policy bodies such as the United States Congress and executive offices including the Office of Management and Budget.

History and Development

Established in 1996, the initiative arose amid rising attention from organizations like the United Nations and the World Health Organization to antimicrobial resistance challenges highlighted during conferences such as the United Nations General Assembly infectious disease discussions. Early collaborators included the Food Safety and Inspection Service and state public health laboratories associated with programs at Centers for Disease Control and Prevention (CDC), while scientific input came from researchers affiliated with Centers for Disease Control and Prevention laboratories and universities like University of Florida and North Carolina State University. Over time the system expanded assays, laboratory networks, and data-sharing protocols influenced by reports from bodies including the Institute of Medicine and commissions such as the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria. Major milestones included adoption of standardized susceptibility testing influenced by guidelines from the Clinical and Laboratory Standards Institute and adoption of molecular methods inspired by advances at institutes like the National Institutes of Health.

Methodology and Surveillance Components

The system integrates three core components: human clinical surveillance coordinated through networks such as Active Bacterial Core surveillance, animal surveillance conducted with partners including the United States Department of Agriculture, and retail meat surveillance performed in collaboration with the Food and Drug Administration. Laboratories employ phenotypic susceptibility testing guided by standards from the Clinical and Laboratory Standards Institute and molecular characterization using techniques developed at institutions like the Broad Institute and Cold Spring Harbor Laboratory. Data management uses bioinformatics resources and protocols influenced by the National Center for Biotechnology Information and data standards from the World Health Organization Global Antimicrobial Resistance Surveillance System. Sampling frames are informed by food production statistics from the United States Department of Agriculture Economic Research Service and patient data coordinated with state public health departments such as the Massachusetts Department of Public Health.

Findings and Impact

Reports have documented resistance trends among pathogens such as multidrug-resistant Salmonella and fluoroquinolone-resistant Campylobacter, influencing policy actions by agencies like the Food and Drug Administration and legislative oversight by the United States Congress. Analyses published by investigators at Centers for Disease Control and Prevention and academic collaborators including University of Minnesota and University of California, Davis have linked resistance patterns to antimicrobial use in livestock raised in regions served by processors regulated under the Food Safety and Inspection Service. Findings have informed guidance from public health authorities including the Advisory Committee on Immunization Practices and stewardship initiatives led by hospitals affiliated with Mayo Clinic and Cleveland Clinic. Internationally, data contributed to assessments by the World Health Organization and informed strategies adopted by national programs such as the United Kingdom Department of Health and Social Care and the European Commission.

Governance and Funding

The program is governed through interagency agreements among the Centers for Disease Control and Prevention, the Food and Drug Administration, and the United States Department of Agriculture, with operational coordination involving state public health laboratories and academic partners such as Cornell University and Michigan State University. Funding mechanisms include appropriations by the United States Congress, grants administered by the Centers for Disease Control and Prevention Foundation, and cooperative agreements with state health departments and academic centers. Budgetary oversight has been exercised through executive review offices including the Office of Management and Budget and audit inquiries involving the Government Accountability Office.

Criticism and Challenges

Critiques have addressed limitations in sampling representativeness noted by analysts at institutions such as RAND Corporation and scholars from Georgetown University and concerns about timeliness raised by public health experts at Columbia University. Challenges include laboratory capacity disparities across state programs supported variably by agencies like the Association of Public Health Laboratories and debates over data sharing and privacy involving law firms and policy scholars at Brookings Institution. Methodological criticisms have referenced evolving standards from the Clinical and Laboratory Standards Institute and calls for integration with broader One Health initiatives advocated by the World Organisation for Animal Health and the Food and Agriculture Organization of the United Nations.

Related Programs and International Collaboration

The system collaborates with domestic programs such as the National Healthcare Safety Network and international initiatives including the Global Antimicrobial Resistance Surveillance System (GLASS) and bilateral efforts with agencies like Public Health England and the European Centre for Disease Prevention and Control. Academic consortia at University of Oxford, Imperial College London, and McGill University engage in comparative analyses, while partnerships with organizations such as the Bill & Melinda Gates Foundation and Wellcome Trust support research on resistance mechanisms. Multilateral coordination involves the World Health Organization, the Food and Agriculture Organization of the United Nations, and the World Organisation for Animal Health to harmonize surveillance, laboratory methods, and policy responses.

Category:Antimicrobial resistance Category:Public health surveillance in the United States